Andrew Hirsch, President & CEO at C4 Therapeutics, Inc. (CCCC), bought 10,000 shares at $8.40 ($84K) on 2022-04-12, disclosed to the SEC on 2022-04-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.